Oestrogen Induced Ovarian Hyperplasia Leading to Cancer in the Rat Ovary
Abstract
ABSTRACT The present study was aimed to assess the carcinogenic effect of a highly potent semisynthetic oestrogen, ethinyl oestradiol (EO) on the rat ovary. The EO was administered to different groups of rats @ 250, 500 and 750 μg/kg body weight, orally, weekly for 16 and 20 weeks. On the 17th week, the ovarian tissues revealed marked congestion and fibrosis. Degeneration and necrosis of follicular tissues were also noticed. On the 21st week, these changes were more marked. In general, extensive fibrosis, thickening of blood vessel walls, follicular tissue degeneration and necrosis were noticed. At this period, EO (750 μg/kg) caused papillary proliferation in surface epithelium and hyperplasia of follicular cells, which indicated the development of cancer in the rat ovary. The extent and severity of ovarian damage were dose and time dependent, suggesting that the EO at higher dose for prolonged period (750 μg/kg, orally, weekly for 20 weeks) may produce hyperplasia leading to cancer in the ovary.Downloads
Download data is not yet available.
Downloads
How to Cite
Govind Pandey, D. (2011). Oestrogen Induced Ovarian Hyperplasia Leading to Cancer in the Rat Ovary. International Journal of Pharmaceutical & Biological Archive, 2(2). Retrieved from http://ijpba.info/index.php/ijpba/article/view/219
Issue
Section
Research Articles
License
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.